StockData
Beta Bionics, Inc. logo

Beta Bionics, Inc. (BBNX) stock

BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.72−0.49 (-3.22%)

Close on Nov 17, 2026Market cap $800.28MP/E –Yield –

Beta Bionics cash

Cash and short-term investments held at the end of each period.

Beta Bionics's cash was $240.20M at Sep 30, 2026. For fiscal 2025 it was $219.13M, up 111.4% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$219.13M+111.4%
FY2024Dec 31, 2024$103.68M+7.1%
FY2023Dec 31, 2023$96.85M+248.7%
FY2022Dec 31, 2022$27.78M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$240.20M+5.0%
Q2 FY2026Jun 30, 2026$180.49M-27.7%
Q1 FY2026Mar 31, 2026$199.52M-13.8%
Q4 FY2025Dec 31, 2025$219.13M+111.4%
Q3 FY2025Sep 30, 2025$228.69M+1208.2%
Q2 FY2025Jun 30, 2025$249.72M+1816.6%
Q1 FY2025Mar 31, 2025$231.47M+948.7%
Q4 FY2024Dec 31, 2024$103.68M+7.1%
Q3 FY2024Sep 30, 2024$17.48M-37.1%
Q2 FY2024Jun 30, 2024$13.03M–
Q1 FY2024Mar 31, 2024$22.07M–
Q4 FY2023Dec 31, 2023$96.85M–
Q4 FY2022Dec 31, 2022$27.78M–

More Beta Bionics figures

See a number that looks wrong?